Increased 18F fluorodeoxyglucose uptake of a vertebral hemangioma responsible for oncogenic osteomalacia

European Journal of Internal Medicine

Volumn 17, Issue 3, 2006, Pages 223-

  Vandergheynst, F ^a   Van Dorpe, J ^a   Goldman, S ^a   Decaux, G ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; CASE REPORT; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HEMANGIOMA; HUMAN; LAMINECTOMY; LETTER; MALE; OSTEOMALACIA; PHYSICAL EXAMINATION; POSITRON; SENSITIVITY ANALYSIS;

EID: 33646001433     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.11.008     Document Type: Letter

References (2)

1. Dupond J.L., Mahammedi H., Magy P., Blagosklonov O., Meaux-Ruault N., and Kantelip B. Detection of mesenchymal tumor responsible for hypophosphatemic osteomalacia using FDG-PET. Eur J Int Med 16 (2005) 445-446
2. Seufert J., Ebert K., Muller J., Eulert J., Hendrich C., Werner E., et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345 (2001) 1883-1888